Academic Journal
Q2Journal of Endocrinological Investigation
About Journal of Endocrinological Investigation
Journal of Endocrinological Investigation is a scholarly journal published by Springer Science and Business Media Deutschland GmbH. SCImago 2025 lists it in Q2, with an SJR of 1.25 and H-index of 108.
Coverage: 1978-2026. Research categories: Endocrinology (Q2); Endocrinology, Diabetes and Metabolism (Q2).
Verified field sources
- Journal Impact Factor: 4.0 — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
- Impact Factor year: 2025 — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
- Editor(s): Uberto Pagotto MD, PhD (Editor-in-Chief) — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
Source-backed journal facts
Topics in published research
Thyroid Disorders and Treatments; Pituitary Gland Disorders and Treatments; Growth Hormone and Insulin-like Growth Factors; Thyroid Cancer Diagnosis and Treatment; Adrenal Hormones and Disorders; Hormonal and reproductive studies.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
4,790.00 USD; 3,790.00 EUR; 2,990.00 GBP
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Effects of C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) on weight loss, adipocytokines levels, and insulin resistance after a high polyunsaturated fat diet in obese patients
D. A. de Luis, O. Izaola, R. Aller, B. de La Fuente et al.
2013-12 · DOI: 10.1007/bf03346760Risk factors of sexual dysfunction after transurethral resection of the prostate (TURP): A12 months follow-up
V. Favilla, S. Cimino, C. Salamone, E. Fragalà et al.
2013-12 · DOI: 10.1007/bf03346761Use of parathyroid hormone in hypoparathyroidism
N. E. Cusano, M. R. Rubin, D. Irani, J. Sliney et al.
2013-12 · DOI: 10.1007/bf03346763Industrial endocrine disruptors and polycystic ovary syndrome
E. Palioura, E. Diamanti-Kandarakis
2013-12 · DOI: 10.1007/bf03346762Low serum vitamin D level is associated with high risk of metabolic syndrome in post-menopausal women
H. R. Song, C. H. Park
2013-11 · DOI: 10.1007/bf03346758MicroRNAs: Suggested role in pituitary adenoma pathogenesis
M. R. Gadelha, L. Kasuki, J. Dénes, G. Trivellin et al.
2013-11 · DOI: 10.1007/bf03346759The Gioppino’s family
E. Martino
2013-10 · DOI: 10.1007/bf03347113A multicenter evaluation of immunoassays for follicle-stimulating hormone, luteinizing hormone and testosterone: Concordance, imprecision and reference values
A. Radicioni, A. Lenzi, M. Spaziani, A. Anzuini et al.
2013-10 · DOI: 10.1007/bf03347112Glucose intolerance states in women with the polycystic ovary syndrome
R. Pasquali, A. Gambineri
2013-09 · DOI: 10.1007/bf03346757Clinical efficacy and metabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: A randomized study
D. Romualdi, S. De Cicco, M. Busacca, D. Gagliano et al.
2013-09 · DOI: 10.1007/bf03346756Association of serum pigment epithelium-derived factor with high-sensitivity C-reactive protein in women with polycystic ovary syndrome
Q. Cheng, W. Xia, S. Yang, P. Ye et al.
2013-09 · DOI: 10.1007/bf03346755Comparison of osteoprotegerin and vascular endothelial growth factor in normoalbuminuric Type 1 diabetic and control subjects
A. Esteghamati, A. Arefzadeh, A. Zandieh, M. Salehi Sadaghiani et al.
2013-07 · DOI: 10.1007/bf03347110Cubist portrait of acromegalic woman
F. Guaraldi, F. Vannini
2013-07 · DOI: 10.1007/bf03347111Fatty acid-binding protein 2 Ala54Thr genotype is associated with insulin resistance and leptin levels changes after a high monounsaturated fat diet in obese non-diabetic patients
D. A. de Luis, R. Aller, O. Izaola, M. Gonzalez Sagrado et al.
2013-06 · DOI: 10.1007/bf03347107Insulin autoimmune syndrome induced by methimazole in a patient with Graves’ disease
W.-C. Zhao, J. Jin, J.-Z. Zhang
2013-06 · DOI: 10.1007/bf03347108Professor Antonio Liuzzi (1939–2013)
Marcella Motta, Giuseppe Oppizzi, Canzio Fusè, Alessia Fusè et al.
2013-06 · DOI: 10.1007/bf03347106Mary with Child and Saints — Palma il Vecchio
M. Parasiliti Caprino, E. Ghigo, F. Guaraldi
2013-05 · DOI: 10.1007/bf03347105The size of the community rather than its geographical location better defines the risk of iodine deficiency: Results of an extensive survey in Southern Italy
F. Aghini-Lombardi, P. Vitti, L. Antonangeli
2013-05 · DOI: 10.1007/bf03347103The European perspective of diabetes prevention: The need for individualization of diabetes prevention
G. Müller, G. Weser, P. E. H. Schwarz
2013-05 · DOI: 10.1007/bf03347104XXXVI National Congress of the Italian Society of Endocrinology
2013-04 · DOI: 10.1007/bf03347277Reviews
Community Reviews
Version History
October 4, 2026 at 8:54 pm
September 25, 2026